Literature DB >> 1533998

T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor.

R M Du Bois1, M Kirby, B Balbi, C Saltini, R G Crystal.   

Abstract

Sarcoidosis, a granulomatous disease of unknown etiology, is characterized at sites of disease such as the lung by the accumulation of large numbers of T-lymphocytes. To differentiate whether the T-cells accumulate in organs nonspecifically (e.g., through chemotaxis or tumorlike proliferation) or more specifically through an antigen-driven ordered immune response, the present study capitalized on the knowledge that specific antigen stimulation of T-cells requires antigen interactions with the T-cell antigen receptor (TCR), resulting in a decrease in the number of surface TCR and a concomitant increase in TCR mRNA levels, i.e., if lung T-cell accumulation in pulmonary sarcoid results from an ordered immune response, lung, but not blood, T-cells should demonstrate evidence of recent triggering of the alpha beta receptor, the most abundant type of TCR. The surface density of T-cell surface alpha beta TCR expression was evaluated by flow cytometry with an anti-alpha beta antibody and TCR beta-chain mRNA transcript number quantified by in situ hybridization with 35S-labeled antisense and sense cRNA probes. Control studies utilizing normal blood T-lymphocytes stimulated with the anti-CD3 monoclonal antibody, OKT3, in the presence of autologous monocytes, demonstrated the expected down-regulation of surface alpha beta TCR expression and increased beta-chain mRNA transcript number. When lung and blood T-cells of patients with pulmonary sarcoidosis were compared immediately upon recovery (i.e., without in vitro stimulation), the lung T-cells of 10 of 10 subjects demonstrated a decreased surface density of alpha beta TCR compared with their autologous blood T-cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533998     DOI: 10.1164/ajrccm/145.5.1205

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  13 in total

1.  Pancreatitis and duodenitis from sarcoidosis: successful therapy with mycophenolate mofetil.

Authors:  Andrew S O'Connor; Farhad Navab; Michael J Germain; Jonathan K Freeman; Jeffrey G Mulhern; Michael H O'Shea; George S Lipkowitz; Robert L Madden; Gregory L Braden
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

2.  Limited heterogeneity of biased T-cell receptor V beta gene usage in lung but not blood T cells in active pulmonary sarcoidosis.

Authors:  R F Silver; R G Crystal; D R Moller
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

3.  Mycobacterium tuberculosis DNA in tissues affected by sarcoidosis.

Authors:  M L Wilsher; R E Menzies; M C Croxson
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 4.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 5.  Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?

Authors:  Lindsay J Celada; Wonder P Drake
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

6.  Characterization of bronchoalveolar lavage T cell subsets in sarcoidosis on the basis of CD57, CD4 and CD8.

Authors:  T Kurumagawa; S Seki; H Kobayashi; Y Koike; S Kanoh; H Hiraide; K Motoyoshi
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

7.  Gamma/delta T lymphocytes in the blood of patients with sarcoidosis.

Authors:  M L Wilsher; M Hallowes; N M Birchall
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

8.  Clonal analysis of lung and blood T cells in patients with sarcoidosis.

Authors:  M J Garlepp; A H Rose; J E Dench; B W Robinson
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

9.  Spontaneous interleukin 2 release of bronchoalveolar lavage cells in sarcoidosis is a codeterminator of prognosis.

Authors:  J Müller-Quernheim; S Pfeifer; K Kienast; G Zissel
Journal:  Lung       Date:  1996       Impact factor: 2.584

10.  Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis.

Authors:  Kyra A Oswald-Richter; Bradley W Richmond; Nicole A Braun; Joan Isom; Susamma Abraham; Thyneice R Taylor; John M Drake; Daniel A Culver; David S Wilkes; Wonder P Drake
Journal:  J Immunol       Date:  2013-04-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.